BG Medicine, Inc.
SEC CIK 1407038 · BGMD · last insider filing 2016-06-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sohmer Paul R | Director · President & CEO | filed 2013 - 2016 |
| Luber Jeffrey R | Director | filed 2016 - 2016 |
| Afeyan Noubar | Director | filed 2011 - 2015 |
| Wilcox Harry W | Director | filed 2015 - 2015 |
| Oconnor James F O | Director | filed 2015 - 2015 |
| Papadopoulos Stelios | Director | filed 2011 - 2015 |
| Bains Harrison M JR | Director | filed 2011 - 2014 |
| Posner Brian S | Director | filed 2012 - 2014 |
| Harris Timothy J.R. | Director | filed 2011 - 2014 |
| Bancel Stephane | Director · Executive Chairman | filed 2011 - 2014 |
| Muntendam Pieter | Director · President, CEO | filed 2011 - 2012 |
| Bouvier Eric | Director · President, CEO | filed 2012 - 2012 |
| van der Meer Pieter | Director | filed 2011 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Adourian Aram S. | VP, Scientific Affairs | filed 2011 - 2016 |
| Hall Stephen P | EVP & Chief Financial Officer | filed 2013 - 2016 |
| Rader Anastasia | SVP, Executive Operations & HR | filed 2011 - 2014 |
| Abdalian Charles H Jr | EVP & Chief Financial Officer | filed 2012 - 2012 |
| Densel William | General Manager, CardioSCORE | filed 2012 - 2012 |
| Gordon Neal | SVP, Biomarker Discovery | filed 2011 - 2012 |
| Rogers Michael W | EVP, CFO and Treasurer | filed 2011 - 2012 |
| Miller Stephen R. | Chief Commercial Officer | filed 2011 - 2012 |
| Shepherd Wayne K. | VP, Sales and Marketing | filed 2011 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.